Brynjelsen Sean: insider trades.
Brynjelsen Sean reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($6.1M), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- BRYNJELSEN SEAN
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | Director, Officer · President & CEO | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-20 | Eton Pharmaceuticals, Inc. | S | 7,342 | $62.12 | 961,194 | Form 4 |
| 2026-08-20 | Eton Pharmaceuticals, Inc. | S | 36,373 | $61.11 | 968,536 | Form 4 |
| 2026-08-20 | Eton Pharmaceuticals, Inc. | S | 47,307 | $60.17 | 1,004,909 | Form 4 |
| 2026-08-19 | Eton Pharmaceuticals, Inc. | S | 8,978 | $62.65 | 1,052,216 | Form 4 |
| 2026-07-14 | Eton Pharmaceuticals, Inc. | M | 200,000 | $1.37 | 1,061,194 | Form 4 |
| 2026-07-12 | Eton Pharmaceuticals, Inc. | M | 27,500 | — | 861,194 | Form 4 |
Questions
What stock did Brynjelsen Sean buy or sell?
Brynjelsen Sean reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($6.1M), across 1 company.
Is Brynjelsen Sean the same person as other filers with this name?
This page covers SEC CIK 1669976 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/brynjelsen-sean-1669976.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.